Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions. The Company commercializes medicines for eye diseases, high low-density lipoprotein (LDL) cholesterol, and an inflammatory condition and have product candidates in development in other areas, including rheumatoid arthritis, asthma, atopic dermatitis, pain, cancer, and infectious diseases. The Company's marketed products include EYLEA (aflibercept) Injection, Praluent (alirocumab) Injection, ARCALYST (rilonacept) Injection for Subcutaneous Use, Kevzara (sarilumab) Solution for Subcutaneous Injection and ZALTRAP (ziv-aflibercept) Injection for Intravenous Infusion. As of December 31, 2016, the Company had 16 product candidates in clinical development, which consisted of a Trap-based clinical program and 15 fully human monoclonal antibody product candidates.
|
|
|
|
|
The current share price compared to the 52-week high.
The volatility of a stock over a given time period. It is calculated by determining the average standard deviation from the average price of the stock over one month or 21 business days. Historical volatility can be compared with implied volatility to determine if a stock's options are over- or undervalued.
GAAP EPS (TTM) refers to a company's earnings per share (EPS) for the trailing twelve-month (TTM) period. EPS is calculated by dividing the adjusted income available to common stockholders for the trailing twelve months by the trailing twelve-month diluted weighted average shares outstanding.
TD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts.
GAAP P/E is a relative valuation measure used to determine if a stock is expensive in relation to its peers. It is calculated by dividing the current stock price by the sum of the Diluted Earnings Per Share from continuing operations BEFORE Extraordinary Items and Accounting Changes over the last reported 12 months.
TD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts.
Annual Dividend is calculated by multiplying the announced next regular dividend amount times the annual payment frequency. If no new dividend has been announced, the most recent dividend is used. If dividend payments are inconsistent, as with many ADRs, the annual dividend is calculated by totaling the regular dividends paid over the trailing 12 months. Annual Dividend/yield calculations do not guarantee or imply future payment of dividends.
The measure of a security's volatility in relation to the S&P 500. Beta less than 1 means the security's price or NAV has been less volatile than the market. Beta greater than 1 means the security's price or NAV has been more volatile than the market.
Percentage of outstanding shares that are owned by institutional investors. Calculated from current quarterly filing as of today.
The number of shares of a security that have been sold short by investors. It is typically expressed as a percentage of the total number of shares outstanding and is reported on a monthly basis.
January 21, 2021 | |
---|---|
12:01 pm ET | |
PR Newswire | |
January 19, 2021 | |
4:15 pm ET | |
PR Newswire | |
January 12, 2021 | |
6:09 pm ET | |
MarketWatch | |
December 30, 2020 | |
8:41 am ET | |
MarketWatch | |
December 17, 2020 | |
5:00 pm ET | |
PR Newswire | |
December 16, 2020 | |
7:00 am ET | |
PR Newswire | |
December 15, 2020 | |
6:01 am ET | |
Globe Newswire | |
December 02, 2020 | |
10:11 am ET | |
BusinessWire | |
November 30, 2020 | |
7:00 am ET | |
PR Newswire | |
November 25, 2020 | |
8:46 am ET | |
MarketWatch | |
November 23, 2020 | |
2:58 pm ET | |
MarketWatch | |
9:31 am ET | |
PR Newswire | |
November 16, 2020 | |
7:00 am ET | |
PR Newswire | |
November 13, 2020 | |
4:15 pm ET | |
PR Newswire | |
November 09, 2020 | |
5:49 am ET | |
Globe Newswire | |
November 06, 2020 | |
12:13 pm ET | |
MarketWatch | |
November 05, 2020 | |
6:36 am ET | |
MarketWatch | |
6:34 am ET | |
MarketWatch | |
6:34 am ET | |
MarketWatch | |
6:33 am ET | |
MarketWatch | |
October 30, 2020 | |
9:33 am ET | |
MarketWatch | |
9:20 am ET | |
MarketWatch | |
9:12 am ET | |
PR Newswire | |
October 29, 2020 | |
2:32 pm ET | |
PR Newswire | |
12:35 pm ET | |
Zacks | |
7:00 am ET | |
PR Newswire | |
October 28, 2020 | |
5:35 pm ET | |
MarketWatch | |
October 27, 2020 | |
4:30 pm ET | |
PR Newswire | |
October 14, 2020 | |
6:28 pm ET | |
MarketWatch | |
6:28 pm ET | |
MarketWatch | |
October 13, 2020 | |
3:24 pm ET | |
MarketWatch | |
October 11, 2020 | |
8:05 pm ET | |
MarketWatch | |
8:05 pm ET | |
MarketWatch | |
October 08, 2020 | |
8:31 am ET | |
MarketWatch | |
4:06 am ET | |
MarketWatch | |
Go to all current & historical news |
Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.
Options are not suitable for all investors as the special risks inherent to options trading may
expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.
"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.
Copyright © 2021. All rights reserved.